What is the Typical Duration of a Mental Health Rehab Program?

Complex post-traumatic stress disorder (CPTSD) is a unique form of traumatic stress disorder. It develops as a result of prolonged exposure to traumatic events, especially in situations where escape or avoidance is not possible. Unlike classic PTSD, complex PTSD is characterized not only by a reaction to a single traumatic event. Profound changes in emotional regulation, self-perception, and relationships with others also characterize it.

Structured recovery stages play a key role in healing from this problem. They provide a solid foundation for gradual and steady progress. This allows people to move at their own pace, respecting their path to recovery. It is important to realize that healing is possible. Remember, many people successfully overcome the effects of trauma and return to a full and fulfilling life.

What are the symptoms of complex PTSD?

Complex PTSD manifests itself through many interrelated symptoms. Each of them can significantly affect a person's daily life. When the problem is pronounced, not all symptoms necessarily manifest. But some symptoms include:

• Flashbacks formation and intrusive memories. They can occur suddenly and can be extremely realistic. A person may not only visually relive the traumatic events but may also experience physical sensations, smells, and sounds associated with the trauma. These memories often invade the mind without warning, disrupting daily activities.
• Avoidance of reminders of the trauma. This problem with CPTSD manifests itself in a desire to avoid places, people, or situations that may trigger painful memories. It can lead to a significant narrowing of living space and social isolation.
• Difficulty regulating emotions. These conditions manifest themselves in sudden mood swings, outbursts of anger, or deep sadness. The person may have difficulty identifying their feelings or feel emotionally numb.
• Chronic feelings of guilt, shame, or worthlessness. These symptoms often become part of the self-image. People may constantly criticize themselves, feeling "spoiled" or unworthy of happiness and love.
• Dissociation and feeling disconnected from reality. These problems can manifest as a feeling of unreality about what is happening, disconnected from one's own body or emotions. Some describe it as a feeling of "autopilot" or watching your life from the outside.
• Difficulty trusting and maintaining relationships. In complex PTSD, these symptoms are often associated with a deep distrust of people and fear of betrayal. It can manifest in difficulty establishing intimacy, maintaining friendships, or creating romantic connections.

The Three Key Stages of Complex PTSD Recovery

Healing from CPTSD is a structured process that requires a sequential approach. The recovery stages allow for a gradual progression toward recovery, taking into account the individual characteristics of each person. Although the path is not always linear, each stage sets the stage for the next step toward healing.

Establishing Safety and Stabilization

The first and fundamental recovery stages begin with creating a safe physical and emotional environment. This is the cornerstone of the healing process, without which no further progress is possible.

Creating physical safety includes:

• Providing safe housing
• Establishing a stable daily routine
• Meeting basic needs for food, sleep, and physical activity
• Ensuring financial stability

Developing emotional safety involves:

• Mastering stress management techniques (deep breathing, meditation)
• Practicing grounding exercises
• Working with a professional therapist
• Creating a support system of trusted people

At Amae Health, specialists help develop an individualized stabilization plan tailored to each person's unique needs and circumstances. Regular sessions with a therapist create a safe space to explore emotions and develop coping skills.

Processing Traumatic Memories

Once a sufficient level of stability has been achieved, the second stage of overcoming PTSD begins - working with traumatic memories. This stage requires special care and professional support.

Methods of trauma-focused therapy:

• EMDR (Eye Movement Desensitization and Reprocessing):
  
  • Helps to process traumatic memories
  • Reduces the emotional intensity of the memories
  • Promotes integration of traumatic experiences
• Cognitive Behavioral Therapy (CBT):
  
  • Helps identify and change unhealthy thinking patterns
  • Develops anxiety management skills
  • Teaches more adaptive ways of responding
• Somatic Therapy:
  
  • Works with the bodily manifestations of trauma
  • Helps to reconnect with the body
  • Develops the ability to feel safe on a physical level

It is important to realize that processing traumatic memories is not simply retelling traumatic events. It is a controlled process designed to integrate the experience without re-traumatizing it. Grieving and mourning losses are a natural part of this process.

Reconnecting with Daily Life

The third recovery stage focuses on reintegration into everyday life and building a new future. This is when a person re-establish social ties and finds new meaning in life.

Key aspects of reintegration:

• Rebuilding relationships:
  
  • The gradual building of trust
  • Developing communication skills
  • Establishing healthy boundaries
• Developing interests and hobbies:
  
  • Exploring new activities
  • Returning to previous hobbies
  • Developing creative self-expression
• Setting and achieving goals:
  
  • Starting with small, achievable goals
  • Gradually expanding horizons
  • Celebrating each success

It's important to remember that progress is rarely linear. Temporary setbacks are a normal part of the recovery process, not a sign of failure.

Therapeutic Approaches in CPTSD Recovery

Psychotherapy Modalities

Amae Health utilizes a variety of therapeutic approaches tailored to each client's individual needs:

• Dialectical Behavioral Therapy (DBT):
  
  • Develops emotional regulation skills
  • Teaches acceptance and change
  • Helps you cope with crises
• Intra-Family Systems Therapy (IFS):
  
  • Works with different parts of the personality
  • Helps restore inner harmony
  • Promotes self-understanding and acceptance
• Somatic Therapy:
  
  • Restores connection with the body
  • Helps to recognize and regulate bodily sensations
  • Develops resource states

Medication Management

Medication therapy can be a useful adjunct to psychotherapy, although it is not in itself a treatment for CPTSD.

The main groups of medications are:

• Antidepressants (SSRIs, SNRIs) - help manage symptoms of depression and anxiety
• Mood stabilizers - maintain emotional stability
• Sleep medications - help with sleep disorders

It is important to remember that any medication should only be taken under the supervision of a qualified professional. While medications may alleviate certain symptoms, lasting improvement in CPTSD often comes through trauma-focused therapy. Intensive trauma-based treatments have been shown to significantly reduce CPTSD symptoms, with over 85% of patients in one study no longer meeting diagnostic criteria after just eight days of structured therapy.

Holistic & Self-Help Strategies for CPTSD Recovery

Lifestyle Adjustments for Long-Term Healing

Physical Well-being:

• Regular exercise helps reduce stress and improve mood
• A healthy diet supports energy balance
• Quality sleep helps restore the nervous system

Emotional Well-being:

• Practicing mindfulness helps you stay in the present moment
• Meditation reduces anxiety and improves concentration
• Breathing exercises help regulate the emotional state

Building a Personal Support Network

Importance of social support:

• Support groups provide an opportunity to socialize with people with similar experiences from complex PTSD
• Online forums can be a source of information and support
• Healthy boundaries protect against re-traumatization

Building supportive relationships:

• Gradual development of trust
• Open communication about your needs
• Respect for personal boundaries

Your Recovery Journey: What Comes Next?

Recovery from CPTSD is a journey that takes time, patience and support. Every step forward, even the smallest, is a meaningful accomplishment. It is important to remember that you are not alone on this journey.

‍The leadership team at Amae Health brings together deep clinical expertise, personal commitment, and a mission to guide you through every step of recovery. Our professionals take a comprehensive approach, combining a variety of therapies and support methods customized to your individual needs.

Recovery is possible. Every day, people overcome the effects of trauma and return to a full life. Your ability to seek help is already a manifestation of your inner strength and commitment to healing.

Remember what is important in the recovery process:

• Move at your own pace
• Celebrate every accomplishment, even small ones
• Be patient and kind to yourself
• Don't hesitate to ask for help when you need it

Recovery stages from CPTSD may seem difficult, but each step brings you closer to healing. With the right support and tools, you can build a new, more fulfilling life after trauma.

‍

Schizophrenia vs schizoaffective disorder is one of the harder distinctions in psychiatry, and many families hear both terms before anyone settles on one. Both conditions involve psychosis: hallucinations, delusions, and disorganized thinking. The difference is mood. In schizoaffective disorder, major mood episodes (depression, mania, or both) occur alongside the psychosis and are present for most of the illness. In schizophrenia, psychosis is the core of the illness, and any major mood episodes fill only a minority of its course.

‍

That one difference decides how each diagnosis is made, why the label sometimes changes over time, and whether treatment targets psychosis alone or psychosis and mood together.

What Is Schizophrenia?

Schizophrenia affects how a person thinks, feels, and behaves. The National Institute of Mental Health groups its symptoms into three kinds:

‍

• Psychotic symptoms: hallucinations, delusions, and thought disorder, meaning speech or reasoning that is hard to follow.
• Negative symptoms: loss of motivation, loss of interest or enjoyment in daily activities, and withdrawal from social life.
• Cognitive symptoms: problems with attention, concentration, and memory.

‍

People are usually diagnosed between the ages of 16 and 30, after a first episode of psychosis. Under the DSM-5-TR, the American Psychiatric Association's diagnostic manual, the diagnosis requires at least two core symptoms, one of them hallucinations, delusions, or disorganized speech. Signs of the illness must persist for at least six months, with a marked decline in work, relationships, or self-care.

‍

Depression can occur in schizophrenia too. But what matters for the diagnosis is proportion: any major mood episodes that overlap with active psychosis account for only a minority of the illness's total duration.

‍

Psychosis itself is a symptom rather than a diagnosis, and our guide to psychosis vs. schizophrenia explains where one ends and the other begins. Researchers are still working out why schizophrenia develops, and our article on whether schizophrenia is genetic covers what's known about inherited risk.

What Is Schizoaffective Disorder?

Schizoaffective disorder combines the psychotic symptoms of schizophrenia with major mood episodes. MedlinePlus, the National Library of Medicine's health reference, describes it as causing both a loss of contact with reality and mood problems, and notes that it is thought to be less common than schizophrenia or mood disorders.

‍

A schizoaffective disorder diagnosis rests on three requirements in the DSM-5-TR:

‍

1. A mood episode during psychosis. A major depressive or manic episode occurs at the same time as the core symptoms of schizophrenia.
2. Psychosis on its own, too. At some point in the illness, delusions or hallucinations last two weeks or more with no major mood episode present. This is the criterion that separates schizoaffective disorder from a mood disorder with psychotic features, where psychosis appears only during mood episodes.
3. Mood episodes for most of the illness. Symptoms meeting criteria for a major mood episode are present for the majority of the illness's total duration, counting both active and residual phases.

‍

Substance use and other medical conditions also have to be ruled out as the cause. Clinicians then specify a type. In the bipolar type, a manic episode is part of the picture, and major depressive episodes may occur as well. In the depressive type, only major depressive episodes occur.

Schizophrenia vs Schizoaffective Disorder: Key Diagnostic Differences

Why Diagnosis Can Take Time

No blood test, brain scan, or single interview can settle the difference between schizophrenia and schizoaffective disorder. MedlinePlus is plain about it: there are no medical tests to diagnose schizoaffective disorder.

‍

The deciding criterion is also about proportion over time. To say that mood episodes have filled most of an illness, a clinician needs to see a good part of that illness, and early on there often isn't much history to see. Schizophrenia's own criteria require six months of continuous signs.

‍

Early presentations overlap, too. A first episode of psychosis with depression could turn out to be schizophrenia, schizoaffective disorder, bipolar disorder with psychotic features, or major depressive disorder with psychotic features. The questions that separate them take time to answer. Does the psychosis continue when mood is stable? For how long? How much of the illness has been dominated by mood episodes?

‍

The research shows how often the picture shifts. A 2016 meta-analysis of 31 rediagnosis studies in Bipolar Disorders found that 36% of people first diagnosed with schizoaffective disorder had a different diagnosis at a later assessment, most often schizophrenia (19%) or a mood disorder (14%). The shift ran the other way as well: 55% of people diagnosed with schizoaffective disorder at follow-up had started out with a different diagnosis.

‍

A revised diagnosis usually reflects a clearer view of the pattern, not a failure. Records from earlier treatment, observations from family members, and careful tracking of mood alongside psychotic symptoms all help a psychiatrist get there sooner.

Treatment Approaches for Each

For schizophrenia, antipsychotic medication is the foundation. NIMH explains that these medications can make psychotic symptoms less intense and less frequent; most are taken daily as a pill or liquid, and some are given as an injection once or twice a month. Medication works alongside psychosocial treatment, and NIMH lists cognitive behavioral therapy, behavioral skills training, supported employment, and cognitive remediation among the options. For early psychosis, coordinated specialty care brings psychotherapy, medication, case management, employment and education services, and family education and support into a single plan.

‍

Schizoaffective disorder treatment adds a second target: the mood episodes. MedlinePlus describes antipsychotic medicines for the psychotic symptoms, antidepressants or mood stabilizers for the mood symptoms, and talk therapy plus support with work and daily skills. Which mood medication is used depends on the pattern of episodes, particularly whether mania has been part of the illness.

‍

In both conditions, medication is one part of the plan, not the whole of it. For more depth, see what the best treatment for schizophrenia looks like, and our page on how we treat psychosis describes how our teams coordinate that care.

Course and Outlook

Neither label is a forecast. Both conditions vary widely from person to person.

‍

Because its mood episodes come and go, schizoaffective disorder often follows a more up-and-down course than schizophrenia, whose symptoms tend to be more continuous. MedlinePlus notes that people with schizoaffective disorder have a better chance of returning to their previous level of functioning than people with most other psychotic disorders. It also notes that long-term treatment is often needed.

‍

For both diagnoses, improvement is realistic, and it usually builds through steady treatment over time, with adjustments along the way, rather than arriving all at once.

Getting an Accurate Diagnosis and Care

Sorting out schizophrenia vs schizoaffective disorder is rarely a one-visit job. Getting it right shapes the whole treatment plan: it decides whether care targets psychosis alone or psychosis and mood together, and it gives families a clearer sense of what to watch for.

‍

Schizophrenia and schizoaffective disorder are among the conditions we specialize in at Amae. At our integrated outpatient clinics for adults 18 and older, the psychiatrist, therapist, primary care provider, and peer mentor work from one shared plan, so diagnosis, medication, and support stay coordinated instead of scattered across offices. If a diagnosis in your family still feels unsettled, talk with an Amae psychiatrist about diagnosis and care. In a crisis, the 988 Suicide and Crisis Lifeline answers by call or text, day or night.

Frequently Asked Questions

Is schizoaffective disorder more or less severe than schizophrenia?

Neither is simply more severe. They differ in pattern: schizoaffective disorder adds major mood episodes to psychosis. MedlinePlus notes that people with schizoaffective disorder have a better chance of returning to their previous level of functioning than people with most other psychotic disorders, but outcomes vary widely from person to person.

Can schizoaffective disorder turn into schizophrenia, or vice versa?

A diagnosis can change as a clinician sees more of the illness, particularly whether mood episodes keep occurring alongside psychosis. In one meta-analysis, about a third of schizoaffective diagnoses changed at reassessment, most often to schizophrenia. That reflects a clearer picture, not one condition becoming another.

How long does it take to get an accurate diagnosis?

Often several months. Schizophrenia requires at least six months of continuous signs, and schizoaffective disorder depends on how much of the whole illness has involved mood episodes, which takes time to observe. No single test gives an immediate answer.

Do schizophrenia and schizoaffective disorder need the same medications?

Both use antipsychotic medication as the foundation. Schizoaffective disorder usually adds a mood stabilizer or an antidepressant, depending largely on whether the mood episodes have included mania. The right combination is worked out individually with a psychiatrist.

Is schizoaffective disorder the same as bipolar disorder with psychotic features?

No. In bipolar disorder with psychotic features, psychosis happens only during mood episodes. Schizoaffective disorder requires at least two weeks of delusions or hallucinations with no mood episode present, a distinction written into the DSM-5-TR criteria.

Are schizophrenia and schizoaffective disorder treated at Amae Health?

Yes. Both are among the conditions we specialize in. We treat adults 18 and older through integrated outpatient care, where one team coordinates medication, therapy, physical health, and peer support.

‍

Citations

1. National Institute of Mental Health. Schizophrenia. https://www.nimh.nih.gov/health/publications/schizophrenia
2. MedlinePlus, U.S. National Library of Medicine. Schizoaffective disorder. https://medlineplus.gov/ency/article/000930.htm
3. Santelmann H, Franklin J, Bußhoff J, Baethge C. Diagnostic shift in patients diagnosed with schizoaffective disorder: a systematic review and meta-analysis of rediagnosis studies. Bipolar Disorders. 2016;18(3):233-246. https://pubmed.ncbi.nlm.nih.gov/27226263/
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
5. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍

Finishing a course of TMS and feeling like yourself again brings a new worry: will it hold? How long do TMS results last, and what happens if the depression comes back? The research is more encouraging than many people expect. Among people who respond to a course, roughly half to nearly two-thirds are still responding a year later, and when symptoms do return, restarting TMS brought back the improvement for most people in the research.

‍

None of that predicts any one person's course. It does show what tends to help results last, and why the months after treatment deserve a plan of their own.

What "Lasting" Means: Response vs. Remission

Two terms do most of the work in durability research. A person has responded when their depression scores fall by at least half on a standard rating scale. They're in remission when scores drop low enough that the depression is largely gone.

‍

Durability studies then ask a narrower question than the original trials did: of the people who responded or reached remission by the end of a course, how many were still doing well months later? That framing matters when you read the numbers. A result such as 62.5% of people keeping their response for a year describes people who had already responded, not everyone who started TMS. Those follow-up checks happen at set points, typically three, six, and 12 months after a course, so durability is reported as the share of people still responding at each checkpoint.

What the Research Shows About Durability

The most direct data come from a 2014 study in The Journal of Clinical Psychiatry that followed people with medication-resistant major depression for a year after they finished TMS at 42 U.S. clinical practices. Of the 257 people who completed a course and agreed to follow-up, 120 had responded or reached remission by the end of treatment. Of those 120, 75 (62.5%) kept meeting response criteria through the full 12 months.

‍

Two details shape that result. The study used a practical approach after the course: continued antidepressant medication, plus access to more TMS if symptoms returned. And over the year, 93 participants (36.2%) had TMS reintroduced at some point, averaging about 16 treatment days. So the 62.5% reflects TMS inside ongoing care, not a single course left to stand on its own.

‍

A 2019 meta-analysis in Brain Stimulation pooled 19 studies of people who had responded to a TMS course. About two-thirds were still responding at three months, about 53% at six months, and about 46% at one year. The authors' summary: roughly half of responders keep their response for up to a year after a successful course.

‍

Read together, the two studies give a realistic range of around half to nearly two-thirds of responders still doing well a year out. The other side of those numbers matters just as much. A meaningful share of people see symptoms return within the first year, and planning for that possibility is part of good care, not a sign that treatment failed.

Factors That Influence How Long Results Last

The research has identified a few patterns, mostly at the level of groups rather than individuals:

‍

• Maintenance treatment. In the 2019 meta-analysis, studies that included maintenance treatment showed higher sustained response at some time points.
• The mix of people studied. Studies with a higher proportion of women also showed higher sustained response, a group-level pattern that says nothing reliable about any one person.
• Continued medication. The best-known durability results come from people who stayed on antidepressants after TMS, so those numbers describe that combination.
• A completed course. Durability figures come from people who finished a full acute course. They don't describe what happens after a partial one.

‍

Clinicians also weigh a person's history when planning follow-up, such as how many depressive episodes they've had and how many treatments failed before TMS. The findings above don't establish how much those factors change the odds, so they inform a clinician's judgment rather than supply a number.

Maintenance TMS: What It Is and Who May Need It

TMS maintenance treatment means periodic sessions after the main course, scheduled to protect a response rather than to answer a relapse. Schedules vary between providers and between people, and no single schedule has become standard.

‍

The evidence supports the idea without settling the details. The 2019 meta-analysis found maintenance associated with more durable response, and its authors suggested maintenance be considered in practice and tested in future trials. That's a promising signal, not a proven protocol. Maintenance TMS is also separate from staying on medication: in both the year-long and six-month studies, people continued antidepressants whether or not they received more TMS.

‍

Not everyone needs it. Some people stay well for long stretches without it. Whether maintenance makes sense for a particular person is a judgment a psychiatrist makes from their history and how they're doing in the months after the course.

Can TMS Be Repeated If Symptoms Return?

Yes, and the research on restarting TMS is among the most reassuring parts of this topic. In a six-month study in Brain Stimulation, people whose depression had improved by at least a quarter with TMS stopped treatment gradually over three weeks while starting maintenance antidepressant medication. In that study, worsening had a specific meaning: a clinician-rated decline that held for two consecutive weeks, which triggered restarting TMS. Over the next 24 weeks, 38% had symptoms worsen enough to restart TMS, and 32 of those 38 people (84%) regained their improvement. Only 10% of the 99 people whose results were reported met the study's definition of relapse.

‍

A repeat course is different from maintenance. Maintenance is planned in advance to hold a response; a repeat course starts because symptoms have come back. In the year-long study described above, about a third of participants had TMS reintroduced at some point. Whether and when to restart is a decision made with a psychiatrist, based on how symptoms are changing.

What Helps Results Last Longer

Beyond maintenance and continued medication, two more things help, though neither promises that results will last for a particular person:

‍

• Catching changes early. In the six-month study, regular assessments flagged worsening symptoms, and most people who restarted TMS at that point regained their improvement.
• Staying connected to care. Therapy and regular psychiatric visits mean someone is watching for early changes between treatments.

‍

Knowing what returning depression tends to look like makes early changes easier to catch: shifts in sleep or appetite, lower energy, less interest in usual activities, and a low mood that lingers instead of lifting after a few days. When those signs show up, reaching out sooner gives a care team more options, and our guide on how to ask for help when depressed covers how to start that conversation.

‍

These describe what research associates with better long-term results in groups of patients. They aren't instructions for any one person's treatment plan; that's a psychiatrist's call, made with the whole history in view.

Talking to a Psychiatrist About a Long-Term Plan

A TMS course is the start of a plan, not the end of one. The months afterward are when follow-up, medication decisions, and a clear plan for what happens if symptoms return matter most.

‍

At Amae, TMS sits inside our integrated care model, where psychiatric care, therapy, primary care, and peer support stay linked after the course ends. We provide TMS therapy for major depressive disorder at our Los Angeles clinic and at our Bay Area clinics in Los Altos and San Mateo. Commercial insurance plans and cash pay are both accepted, and our intake team handles prior authorization. To map out what comes after a course, talk with an Amae psychiatrist about a long-term plan. Anyone in crisis can reach the 988 Suicide and Crisis Lifeline by call or text.

Frequently Asked Questions

How long do TMS results typically last?

For many people, months to a year or longer, though it varies. In a year-long study of people who responded to TMS, 62.5% kept meeting response criteria for the full 12 months. A 2019 meta-analysis found that about half of responders were still responding at one year.

What percentage of people relapse after TMS?

Some return of symptoms within a year is common. In the 2019 meta-analysis, roughly half of responders were no longer responding at one year. That isn't always a full relapse: in a six-month study, 38% had symptoms worsen enough to restart TMS, while 10% met the study's definition of relapse.

Can TMS be repeated if depression comes back?

Yes. In a six-month study, 84% of people whose symptoms worsened regained their improvement when TMS was restarted. A repeat course is different from ongoing maintenance sessions, and the decision is made with a psychiatrist based on individual history.

Do I need maintenance TMS sessions after my initial course?

Not necessarily. Some people stay well without them, and there is no standard maintenance schedule across providers. Research links maintenance with longer-lasting response, so whether it fits is a decision a psychiatrist makes based on your response and how closely symptoms are being monitored.

What can help TMS results last longer?

The research points to planned follow-up, continued medication when it's part of the plan, and catching symptom changes early. These are general findings from groups of patients, not instructions for any one person's treatment.

Is maintenance TMS covered by insurance?

It depends on the insurer and on whether sessions are billed as maintenance or as a new course for returning symptoms, since coverage can differ between the two. Ask the provider to verify benefits with your insurer before sessions begin.

‍

Citations

1. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. Journal of Clinical Psychiatry. 2014;75(12):1394-1401. https://pubmed.ncbi.nlm.nih.gov/25271871/
2. Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimulation. 2019;12(1):119-128. https://pubmed.ncbi.nlm.nih.gov/30344109/
3. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation. 2010;3(4):187-199. https://pubmed.ncbi.nlm.nih.gov/20965447/
4. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍